Ratings by Benchmark (Robert Wasserman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/2/2024 | Integer Holding | ITGR | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2024 | Anebulo Pharmaceuticals | ANEB | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 8/22/2024 | Nephros | NEPH | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 8/20/2024 | AbCellera Biologics | ABCL | Downgrade | Hold (Buy) |
2.71 (2.50) |
-7.75% | Details | |
| 8/19/2024 | Codexis, Inc. | CDXS | Downgrade | Hold (Buy) |
2.91 (3.16) |
8.59% | Details | |
| 8/14/2024 | Immunoprecise Antibodies Ltd. | IPA | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 6/25/2024 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 6/20/2024 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | BioLife Solutions | BLFS | Upgrade | Buy (Neutral) |
19.54 (24.54) |
25.59% | Details | |
| 3/28/2024 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Nephros | NEPH | Upgrade | Speculative Buy (Hold) |
3.02 (1.58) |
-47.68% | Details | |
| 3/7/2024 | Emergent BioSolutions | EBS | Upgrade | Buy (Hold) |
3.26 (9.35) |
186.81% | Details | |
| 2/29/2024 | Codexis, Inc. | CDXS | Upgrade | Buy (Hold) |
3.72 (3.16) |
-15.05% | Details | |
| 2/22/2024 | AbCellera Biologics | ABCL | Upgrade | Buy (Hold) |
4.81 (2.50) |
-48.02% | Details | |
| 12/4/2023 | Repligen | RGEN | Downgrade | Hold (Buy) |
164.94 (136.71) |
-17.12% | Details | |
| 11/7/2023 | Codexis, Inc. | CDXS | Downgrade | Hold (Buy) |
1.75 (3.16) |
80.57% | Details | |
| 11/6/2023 | AbCellera Biologics | ABCL | Downgrade | Hold (Buy) |
4.70 (2.50) |
-46.81% | Details | |
| 11/1/2023 | Bio-Techne Corp. | TECH | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2023 | AbCellera Biologics | ABCL | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2023 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
4.42 (9.35) |
111.54% | Details | |
| 8/25/2023 | Molekule Group, Inc. | MKUL | Downgrade | Hold (Buy) |
1.19 (0.05) |
-95.8% | Details | |
| 7/28/2023 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2023 | Intensity Therapeutics, Inc. | INTS | New Coverage | Speculative Buy (N/A) |
5.89 (3.75) |
-36.33% | Details | |
| 5/10/2023 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2023 | OmniAb, Inc. | OABI | New Coverage | Buy (N/A) |
3.59 (3.99) |
11.14% | Details | |
| 4/10/2023 | Emergent BioSolutions | EBS | Upgrade | Buy (Hold) |
10.56 (9.35) |
-11.46% | Details | |
| 3/28/2023 | Repligen | RGEN | New Coverage | Buy (N/A) |
160.25 (164.94) |
2.93% | Details | |
| 3/21/2023 | Immunoprecise Antibodies Ltd. | IPA | Downgrade | Speculative Buy (Buy) |
3.08 (0.63) |
-79.55% | Details | |
| 3/16/2023 | Champions Oncology | CSBR | Downgrade | Hold (Buy) |
4.10 (4.79) |
16.83% | Details | |
| 2/14/2023 | Anebulo Pharmaceuticals | ANEB | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 2/13/2023 | Proto Labs | PRLB | Upgrade | Buy (Hold) |
34.43 (28.71) |
-16.61% | Details | |
| 12/8/2022 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | AeroClean Thechnologies Inc. | AERC | Downgrade | Speculative Buy (Buy) |
3.27 (3.40) |
3.98% | Details | |
| 11/10/2022 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
12.85 (9.35) |
-27.24% | Details | |
| 11/2/2022 | Bio-Techne Corp. | TECH | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2022 | Thor Industries Inc. | THO | Downgrade | Hold (Buy) |
79.27 (108.64) |
37.05% | Details | |
| 10/24/2022 | Danaher | DHR | Downgrade | Hold (Buy) |
244.59 (270.03) |
10.4% | Details | |
| 8/18/2022 | AeroClean Thechnologies Inc. | AERC | Upgrade | Speculative Buy (Hold) |
4.34 (3.40) |
-21.66% | Details | |
| 7/15/2022 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2022 | AeroClean Thechnologies Inc. | AERC | Downgrade | Hold (Buy) |
17.25 (4.34) |
-74.84% | Details | |
| 6/7/2022 | AeroClean Thechnologies Inc. | AERC | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/17/2022 | Anebulo Pharmaceuticals | ANEB | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/9/2022 | Nephros | NEPH | Downgrade | Hold (Speculative Buy) |
2.21 (1.58) |
-28.51% | Details | |
| 2/22/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2022 | AeroClean Thechnologies Inc. | AERC | New Coverage | Speculative Buy (N/A) |
4.94 (17.25) |
249.19% | Details | |
| 1/20/2022 | Emergent BioSolutions | EBS | Upgrade | Buy (Neutral) |
45.59 (9.35) |
-79.49% | Details | |
| 12/21/2021 | AbCellera Biologics | ABCL | New Coverage | Buy (N/A) |
14.60 (2.50) |
-82.88% | Details | |
| 11/8/2021 | Emergent BioSolutions | EBS | Downgrade | Hold (Buy) |
52.61 (9.35) |
-82.23% | Details | |
| 10/29/2021 | Proto Labs | PRLB | Downgrade | Hold (Buy) |
58.64 (34.43) |
-41.29% | Details | |
| 10/25/2021 | Immunoprecise Antibodies Ltd. | IPA | New Coverage | Buy (N/A) |
6.19 (0.63) |
-89.82% | Details | |
| 9/22/2021 | Thermo Fisher Scientific | TMO | Maintain | Hold (N/A) |
|
Details | ||
| 7/16/2021 | Danaher | DHR | New Coverage | Buy (N/A) |
280.95 (270.03) |
-3.89% | Details | |
| 7/16/2021 | Thermo Fisher Scientific | TMO | New Coverage | Buy (N/A) |
514.48 (598.61) |
16.35% | Details | |
| 5/25/2021 | Anebulo Pharmaceuticals | ANEB | New Coverage | Buy (N/A) |
8.00 (1.95) |
-75.63% | Details | |
| 5/14/2021 | BioLife Solutions | BLFS | Downgrade | Neutral (Buy) |
29.53 (24.54) |
-16.9% | Details | |
| 4/13/2021 | Bio-Techne Corp. | TECH | Maintain | Buy (N/A) |
|
Details | ||
| 4/7/2021 | Emergent BioSolutions | EBS | New Coverage | Buy (N/A) |
79.25 (9.35) |
-88.2% | Details | |
| 3/23/2021 | BioLife Solutions | BLFS | Upgrade | Buy (Hold) |
38.57 (24.54) |
-36.38% | Details | |
| 1/21/2021 | Halozyme Therapeutics | HALO | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | BioLife Solutions | BLFS | Downgrade | Hold (Buy) |
22.57 (24.54) |
8.73% | Details | |
| 7/15/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2020 | Halozyme Therapeutics | HALO | New Coverage | Buy (N/A) |
26.81 (59.18) |
120.74% | Details | |
| 5/14/2020 | Bio-Techne Corp. | TECH | New Coverage | Buy (N/A) |
261.83 (74.78) |
-71.44% | Details | |
| 5/14/2020 | Proto Labs | PRLB | New Coverage | Buy (N/A) |
96.62 (58.64) |
-39.31% | Details | |
| 5/14/2020 | Integer Holding | ITGR | New Coverage | Buy (N/A) |
70.64 (129.11) |
82.77% | Details | |
| 3/10/2020 | Codexis, Inc. | CDXS | New Coverage | Buy (N/A) |
11.43 (3.16) |
-72.35% | Details | |
| 2/19/2020 | BioLife Solutions | BLFS | New Coverage | (N/A) |
15.54 (24.54) |
57.92% | Details | |
| 2/6/2020 | Ligand Pharma | LGND | New Coverage | Buy (N/A) |
92.19 (104.78) |
13.66% | Details | |
| 11/18/2019 | Champions Oncology | CSBR | New Coverage | Speculative Buy (N/A) |
5.39 (4.79) |
-11.13% | Details | |
| 10/24/2019 | Nephros | NEPH | New Coverage | Speculative Buy (N/A) |
9.61 (1.58) |
-83.56% | Details |
